Press release
Rising Diabetes Prevalence Fuels Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market: Major Factor in the Transformation of the Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market in 2025
Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market
The exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market has also experienced strong growth. It is expected to grow from $5.69 billion in 2024 to $6.17 billion in 2025, reflecting a CAGR of 8.4%. This growth is attributed to the increasing prevalence of underlying conditions, advancements in diagnostic tools, pharmaceutical innovations, and the expansion of global healthcare access.
The exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market is forecasted to grow strongly, reaching $8.32 billion by 2029 at a CAGR of 7.8%. The growth is driven by telemedicine, remote monitoring, AI and data analytics, patient education, and regulatory changes. Trends include personalized treatment approaches, the development of novel therapies, minimally invasive diagnostics, and collaborative care models.
What Key Elements Are Boosting Growth in the Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market?
The rising prevalence of diabetes is expected to accelerate the growth of the exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market. Diabetes is a chronic metabolic disorder marked by high blood sugar levels due to the body's inability to produce or use insulin effectively. EPI therapy, including pancreatic enzyme replacement therapy (PERT), can improve nutrient absorption and glycemic control for people with both diabetes and EPI. For instance, in June 2024, NHS England reported that pre-diabetes cases in the UK rose by 18% in 2023, with cases among individuals under 40 increasing by 25%. This growth in diabetes cases is driving the demand for EPI therapeutics and diagnostics.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12992&type=smp
Who Are the Major Industry Players Fueling Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Expansion?
Major companies operating in the exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market are Pfizer Inc., Merck & Co. Inc., Janssen Pharmaceuticals Inc., AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abott Laboratories, Medtronic PLC, Solvay S.A., Laboratory Corporation of America Holdings (Labcorp), Organon group of companies Metagenics LLC, Allergan PLC, Chiesi Farmaceutici S.p.A., Codexis Inc., Nordmark Arzneimittel GmbH & Co. KG, ChiRhoClin Inc., Digestive Care Inc., Alcresta Therapeutics Inc., Vivus Inc., Cilian AG, Bioserv Diagnostics Gmbh, Anthera Pharmaceuticals Inc., Aptalis Pharma Inc., First Wave BioPharma Inc., EagleBiosciences Inc., ScheBo Biotech AG.
Which Key Developments Are Influencing the Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market?
Companies in the exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market are forming strategic partnerships to improve technology integration and expand market presence. A strategic partnership involves two or more organizations working together to achieve shared goals by combining resources and expertise. For instance, in February 2023, Codexis, Inc., a US-based protein engineering company, and Nestlé Health Science, a Switzerland-based nutrition science company, announced interim results from their Phase 1 clinical trial of CDX-7108, an experimental therapy for treating exocrine pancreatic insufficiency (EPI). These results lay the groundwork for further studies that could significantly enhance treatment options for EPI patients.
How Is the Segmentation of the Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Defined?
The exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market covered in this report is segmented -
1) By Therapies: Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Lifestyle Modifications Approach
2) By Diagnostics: Blood Tests, Magnetic Resonance Imaging (MRI), Endoscopic Ultra-Sonography (EUS), Computerized Tomography (CT) Scanning
3) By Drug Type: Generic, Branded
4) By Distribution Channel: Direct Tender, Retail Pharmacy , Third-Party Distributor, Other Distribution Channels
5) By End User: Hospitals, Specialty Clinics, Homecare, Diagnostic Center, Research And Academic Institutes, Other End Users
Subsegments:
1) By Nutritional Management: Dietary Modifications, Nutritional Supplements
2) By Pancreatic Enzyme Replacement Therapy (PERT): Capsule Formulations, Tablet Formulations, Powder Formulations
3) By Lifestyle Modifications Approach: Weight Management, Physical Activity Recommendations, Smoking Cessation Programs
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-epi-therapeutics-and-diagnostics-global-market-report
What Is the Leading Region in the Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market?
North America was the largest region in the exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market in 2024. The regions covered in exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report?
- Market Size Analysis: Analyze the Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12992
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Diabetes Prevalence Fuels Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market: Major Factor in the Transformation of the Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market in 2025 here
News-ID: 3851817 • Views: …
More Releases from The Business Research Company
Increasing Prevalence Of Cancer Is Driving The Growth Of The Rare Bio Markers Sp …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Rare Biomarkers Specimen Collection And Stabilization Market Size Growth Forecast: What to Expect by 2025?
The market encompassing the collection and stabilization of rare biomarkers has experienced swift expansion lately, projected to increase its valuation from $32.01 billion in 2024 to $35.29 billion by 2025, reflecting a compound annual…
Polymerase Chain Reaction (PCR) Market on Track for Strong Growth, Estimated to …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Polymerase Chain Reaction (PCR) Market Through 2025?
The scale of the polymerase chain reaction (PCR) sector has experienced swift expansion recently, projected to increase from a valuation of $11.42 billion in 2024 to $12.57 billion the subsequent year, reflecting a compound annual…
Emerging Trends to Reshape the Global Pet Obesity Management Market: Innovative …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pet Obesity Management Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market concerned with managing obesity in pets has demonstrated robust expansion recently, projected to escalate from $8.9 billion in 2024 to $9.46 billion by 2025, reflecting a compound annual growth rate of 6.3%.…
Global Progressive Ataxia And Weakness Disorders Market Expected to Achieve 10.9 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Progressive Ataxia And Weakness Disorders Market Size By 2025?
The market encompassing progressive ataxia and weakness disorders has experienced swift expansion lately, with projections showing its value escalating from USD 34.72 billion in 2024 to an anticipated USD 38.54 billion by 2025, reflecting an eleven…
More Releases for EPI
Emerging Trends to Reshape the Silicon EPI Wafer Market: Next-Generation Silicon …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Silicon EPI Wafer Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of the silicon epi wafer has experienced consistent expansion in the previous years, seeing a projected rise from a value of $1.8 billion in 2024 to $1.89 billion in 2025. This…
Consumer Electronics Adoption Fuels The Silicon Epi Wafer Market: Core Growth En …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Silicon EPI Wafer Industry Market Size Be by 2025?
Over recent years, the market size for silicon EPI wafers has seen considerable growth. Predictions indicate an increase from $1.8 billion in 2024 to $1.92 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this historical…
Evolving Market Trends In The Silicon EPI Wafer Industry: Next-Generation Silico …
The Silicon EPI Wafer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Silicon EPI Wafer Market Size During the Forecast Period?
In recent times, the silicon EPI wafer market has witnessed substantial growth. The market size, which stood at $1.8 billion in…
EPI Invests $1 Million USD in the EPI Data Center Futurist Scholarship Program
Singapore (15 June 2023) - EPI, the global leader in data center training, audit & certification, is proud to announce the launch of the EPI Data Center Futurist Scholarship program, accompanied by a significant investment of one (1) million US-Dollar. This transformative initiative aims to provide aspiring professionals with the resources and support they need to acquire the specialized knowledge and skills necessary for success in the dynamic data…
Epi Wafer Market to Surpass Valuation of US$ 5.8 Bn by 2030 with Rising Demand f …
The global Epi Wafer market is estimated to attain a valuation of US$ 5.8 billion by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6% during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
